Fatpipe Inc: Form 10-K for the period ended Mar 31, 2026
Filed with the SEC on May 18, 2026 and accepted by EDGAR at May 18, 2026, 16:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-04-01 to 2026-03-31 | $19.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-04-01 to 2026-03-31 | $1.7m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2025-04-01 to 2026-03-31 | $17.5m | us-gaap:GrossProfit |
| Research and development | 12 months2025-04-01 to 2026-03-31 | $1.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2025-04-01 to 2026-03-31 | $3.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-04-01 to 2026-03-31 | $403.4k | us-gaap:InterestExpense |
| Income tax | 12 months2025-04-01 to 2026-03-31 | −$1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-04-01 to 2026-03-31 | $5.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-04-01 to 2026-03-31 | $0.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-04-01 to 2026-03-31 | $0.36 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-04-01 to 2026-03-31 | 14,006,392 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-04-01 to 2026-03-31 | −$780.4k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-04-01 to 2026-03-31 | $52.5k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2026-03-31 | $5.2m | us-gaap:Cash |
| Current assets | At period end2026-03-31 | $16.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $34.5m | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $4.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $9.3m | us-gaap:Liabilities |
| Long-term debt | At period end2026-03-31 | $4.6m | us-gaap:LongTermDebt |
| Current portion of debt | At period end2026-03-31 | $391.4k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2026-03-31 | $25.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-26-024184. Last ingested by Listed: Oct 27, 2026, 16:07 ET. Listed shows no prices and gives no investment advice.